These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8548604)

  • 1. [Concomitant therapies in the clinical trial in Alzheimer's disease].
    Bermejo F; Ferrari JM
    Rev Neurol; 1995; 23(119):118-24. PubMed ID: 8548604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology in the elderly: psychological and physiological interrelationships.
    Hooyman NW; Gambert SR
    Psychiatr Med; 1983 Dec; 1(4):445-58. PubMed ID: 6152848
    [No Abstract]   [Full Text] [Related]  

  • 3. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in the elderly.
    Med Lett Drugs Ther; 1979 May; 21(10):43-4. PubMed ID: 440199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognition disorders related to psychotropic treatments].
    Bazin N
    Rev Prat; 1994 Nov; 44(17):2332-5. PubMed ID: 7984942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the use of psychopharmaca in geriatric cases.
    Simkó A
    Ther Hung; 1989; 37(4):187-98. PubMed ID: 2576574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive costs and benefits of psychotropic medications in older adults.
    Brooks JO; Hoblyn JC
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):199-214. PubMed ID: 18004007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].
    Gallarda T; Olie JP
    Encephale; 2000; 26(3):72-80. PubMed ID: 10951909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the impact of memantine treatment initiation on psychotropics use: a study from the French national health care database.
    Vidal JS; Lacombe JM; Dartigues JF; Pasquier F; Robert P; Tzourio C; Alpérovitch A
    Neuroepidemiology; 2008; 31(3):193-200. PubMed ID: 18815451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced exacerbations of porphyria.
    Rifkind AB
    Prim Care; 1976 Dec; 3(4):665-85. PubMed ID: 13442
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral outcomes in clinical trials for Alzheimer disease.
    Ferris SH; Mackell JA
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical psychiatry and cardiovascular disease in the aged.
    Neshkes RE; Jarvik LF
    Psychiatr Clin North Am; 1982 Apr; 5(1):171-9. PubMed ID: 6124956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.